For example, Li et al [25] found that deleted in lymphocytic leukemia 1 is upregulated in bladder cancer tissues and patients with high DLEU1 expression exhibits a shorter survival time, and DLEU1 increases cell proliferation, invasion, and cisplatin resistance of bladder cancer cells. This evidence concerns the gene DLEU1 and urinary bladder carcinoma.